Evolution of the human cold/menthol receptor, TRPM8.


Journal

Molecular phylogenetics and evolution
ISSN: 1095-9513
Titre abrégé: Mol Phylogenet Evol
Pays: United States
ID NLM: 9304400

Informations de publication

Date de publication:
07 2019
Historique:
received: 31 01 2019
revised: 09 04 2019
accepted: 09 04 2019
pubmed: 14 4 2019
medline: 18 12 2019
entrez: 14 4 2019
Statut: ppublish

Résumé

Genes showing versatile functions or subjected to fast expansion and contraction during the adaptation of species to specific ecological conditions, like sensory receptors for odors, pheromones and tastes, are characterized by a great plasticity through evolution. One of the most fascinating sensory receptors in the family of TRP channels, the cold and menthol receptor TRPM8, has received significant attention in the literature. Recent studies have reported the existence of TRPM8 channel isoforms encoded by alternative mRNAs transcribed from alternative promoters and processed by alternative splicing. Since the first draft of the human genome was accomplished in 2000, alternative transcription, alternative splicing and alternative translation have appeared as major sources of gene product diversity and are thought to participate in the generation of complexity in higher organisms. In this study, we investigate whether alternative transcription has been a driving force in the evolution of the human forms of the cold receptor TRPM8. We identified 33 TRPM8 alternative mRNAs (24 new sequences) and their associated protein isoforms in human tissues. Using comparative genomics, we described the evolution of the human TRPM8 sequences in eight ancestors since the origin of Amniota, and estimated in which ancestors the new TRPM8 variants originated. In order to validate the estimated origins of this receptor, we performed experimental validations of predicted exons in mouse tissues. Our results suggest a first diversification event of the cold receptor in the Boreoeutheria ancestor, and a subsequent divergence at the origin of Simiiformes.

Identifiants

pubmed: 30980935
pii: S1055-7903(19)30079-X
doi: 10.1016/j.ympev.2019.04.011
pii:
doi:

Substances chimiques

Protein Isoforms 0
RNA, Messenger 0
TRPM Cation Channels 0
TRPM8 protein, human 0
TRPM8 protein, mouse 0
Menthol 1490-04-6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104-118

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Samuel Blanquart (S)

Univ Rennes, Inria, CNRS, IRISA, Rennes F-35000, France. Electronic address: samuel.blanquart@inria.fr.

Anne-Sophie Borowiec (AS)

Inserm, U-1003, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq F-59655, France; Université des Sciences et Technologies de Lille (USTL), Villeneuve d'Ascq F-59655, France.

Philippe Delcourt (P)

Inserm, U-1003, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq F-59655, France; Université des Sciences et Technologies de Lille (USTL), Villeneuve d'Ascq F-59655, France.

Martin Figeac (M)

Université de Lille, Plate-forme de génomique fonctionnelle et structurale, F-59000 Lille, France; CHRU de Lille, Cellule de bioinformatique du plateau commun de séquençage du CHRU de Lille, F-59000 Lille, France.

Christopher A Emerling (CA)

Institut des Sciences de l'Evolution de Montpellier, ISEM, Univ Montpellier, CNRS, IRD, EPHE, Université Montpellier, UMR5554, Montpellier, France.

Andrea S Meseguer (AS)

Institut des Sciences de l'Evolution de Montpellier, ISEM, Univ Montpellier, CNRS, IRD, EPHE, Université Montpellier, UMR5554, Montpellier, France.

Morad Roudbaraki (M)

Inserm, U-1003, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq F-59655, France; Université des Sciences et Technologies de Lille (USTL), Villeneuve d'Ascq F-59655, France.

Natalia Prevarskaya (N)

Inserm, U-1003, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq F-59655, France; Université des Sciences et Technologies de Lille (USTL), Villeneuve d'Ascq F-59655, France.

Gabriel Bidaux (G)

Inserm, U-1003, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq F-59655, France; Université des Sciences et Technologies de Lille (USTL), Villeneuve d'Ascq F-59655, France; Univ Lyon, CarMeN Laboratory, INSERM, INRA, INSA Lyon, Université Claude Bernard Lyon 1, 69550 Bron, France; Hospices Civils de Lyon, Groupement Hospitalier EST, Département de Cardiologie, IHU-OPERA Bâtiment B13, 69550 Bron, France. Electronic address: gabriel.bidaux@univ-lyon1.fr.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH